System of matrix metalloproteinases in infiltrative pulmonary tuberculosis (with and without lung tissue destruction)

Larisa Kiryukhina (Saint Petersburg, Russian Federation), Diljara Esmedlyaeva, Olga Titarenko, Marina Dyakova, Maria Pavlova, Viacheslav Zhuravlev, Larisa Kiryukhina

Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Session: Biomarkers in TB: immunology and physiology
Session type: Poster Discussion
Number: 4527
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Larisa Kiryukhina (Saint Petersburg, Russian Federation), Diljara Esmedlyaeva, Olga Titarenko, Marina Dyakova, Maria Pavlova, Viacheslav Zhuravlev, Larisa Kiryukhina. System of matrix metalloproteinases in infiltrative pulmonary tuberculosis (with and without lung tissue destruction). Eur Respir J 2015; 46: Suppl. 59, 4527

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Immunologic biomarkers and lung injury in active pulmonary tuberculosis
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014

Metalloproteases gene expression and remodeling of lung parenchyma fibers during the progression of elastase induced emphysema
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014


Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias
Source: International Congress 2014 – IPF and surroundings
Year: 2014



Usefulness of a myositis antibody immunoblot in diagnosis of connective tissue disease (CTD) related interstitial lung disease (ILD)
Source: International Congress 2014 – ILDs 4
Year: 2014


Asbestos-related disorders (ARDs): Influence of pleural plaques and pulmonary fibrosis due to asbestos exposure on lung function decline (LFD)
Source: International Congress 2014 – ILDs 5
Year: 2014


HCMV infection triggers the development of interstitial lung diseases in autoimmune disorders
Source: International Congress 2014 – IPF and surroundings
Year: 2014


Matrix metalloproteinases (MMPs) and angiogenesis in lung tissue remodeling in different variants of idiopathic interstitial pneumonia (IIP)
Source: Eur Respir J 2007; 30: Suppl. 51, 137s
Year: 2007

Chemical exposure triggering connective tissue disease with lung involvement
Source: International Congress 2015 – Occupational disease: clinical cases and series
Year: 2015


Serum B cell activating factor (BAFF) as a prognostic biomarker in interstitial lung diseases associated with connective tissue diseases
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014

Type V collagen induced pulmonary fibrosis in C57Bl/6mice
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014

Pulmonary manifestations in rheumatoid arthritis: A hospital based descriptive study
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014


Inhibition of profibrotic signaling in fibroblasts from patients with idiopathic pulmonary fibrosis (IPF) by histone deacetylase-inhibitors (HDACi) or the IPF drug pirfenidone
Source: International Congress 2014 – ILDs 1
Year: 2014

High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation
Source: Eur Respir J 2009; 33: 134-141
Year: 2009



Interleukin-6 in systemic sclerosis and potential correlation with pulmonary involvement
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014


Pulmonary involvement in Moldova lupus study
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013

Lung structure and function relation in systemic sclerosis: Application of lung densitometry
Source: International Congress 2015 – A more functional view of chest pathology
Year: 2015

Collagen V overexpression correlates with IL-17+ cells in C57BL/6 mice pulmonary remodeling
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014

"Cyclophosphamide for the treatment of inflammation driven fibrotic interstitial lung disease"
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014

Mucus production, lung inflammation and functional decay in IPF
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014

Secreted frizzled-related protein 1 (Sfrp1) as key mediator of growth-factor induced invasion
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014